The human ␤ 2 -adrenergic receptor (␤AR) is rapidly desensitized in response to saturating concentrations of agonist by G protein-coupled receptor kinases (GRKs) and cAMP-dependent protein kinase A (PKA) phosphorylation of the ␤AR, followed by ␤-arrestin binding and receptor internalization. ␤AR sites phosphorylated by GRK in vivo have not yet been identified. In this study, we examined the role of the carboxyl terminal serines, 355, 356, and 364, in the GRK-mediated desensitization of the ␤AR. Substitution mutants of these serine residues were constructed in which either all three (S355,356,364A), two (S355,356A and S356,364A), or one of the serines (S356A and S364A) were modified. These mutants were constructed in a ␤AR in which the serines of the PKA consensus site were substituted with alanines (designated PKA Ϫ ) to eliminate any PKA contribution to desensitization, and they were stably transfected into human embryonic kidney 293 cells. Treatment of the PKA Ϫ mutant with 10 M epinephrine for 5 min caused a 3.5-fold increase in the EC 50 value and a 42% decrease in the V max value for epinephrine stimulation of adenylyl cyclase. Substitution of all three serines completely inhibited the epinephrine-induced shift in the EC 50 . Both double mutants, S355,356A and S356,364A, showed a nearly complete loss of the EC 50 shift, whereas the single substitutions, S356A and S364A, caused only a slight decrease in desensitization. None of the mutations altered the epinephrine-induced decrease in V max, which seems to be downstream of the receptor. The triple mutation caused a 45% decrease in epinephrine-induced internalization and a 90 to 95% reduction in phosphorylation of the ␤AR relative to the PKA Ϫ (1.9 Ϯ 0.2-and 16.6 Ϯ 3.8-fold phosphorylation over basal, respectively). The double mutants caused an intermediate reduction in internalization (20 -21%) and phosphorylation (43-52%). None of the serine mutations altered the rate of ␤AR recycling. Our data demonstrate that the cluster of serines within the 355 to 364 ␤AR domain confer the rapid, GRK-mediated, receptor-level desensitization of the ␤AR.
V max value for epinephrine stimulation of adenylyl cyclase. Substitution of all three serines completely inhibited the epinephrine-induced shift in the EC 50 . Both double mutants, S355,356A and S356,364A, showed a nearly complete loss of the EC 50 shift, whereas the single substitutions, S356A and S364A, caused only a slight decrease in desensitization. None of the mutations altered the epinephrine-induced decrease in V max, which seems to be downstream of the receptor. The triple mutation caused a 45% decrease in epinephrine-induced internalization and a 90 to 95% reduction in phosphorylation of the ␤AR relative to the PKA Ϫ (1.9 Ϯ 0.2-and 16.6 Ϯ 3.8-fold phosphorylation over basal, respectively). The double mutants caused an intermediate reduction in internalization (20 -21%) and phosphorylation (43-52%). None of the serine mutations altered the rate of ␤AR recycling. Our data demonstrate that the cluster of serines within the 355 to 364 ␤AR domain confer the rapid, GRK-mediated, receptor-level desensitization of the ␤AR.
The ␤ 2 -adrenergic receptor (␤AR) is rapidly inactivated after exposure to epinephrine. Rapid ␤AR desensitization at high concentrations of epinephrine results from phosphorylation of the receptor by cAMP-dependent protein kinase (PKA) and one or more members of the G protein-coupled receptor kinase (GRK) family (Clark et al., , 1999 Kunkel et al., 1989; Krupnick and Benovic, 1998; Lefkowitz et al., 1998) . Considerable recent evidence supports the proposal that GRK-mediated phosphorylation of receptors greatly promotes their binding to ␤-arrestin, leading to receptor internalization through a clathrin-mediated mechanism (Tsuga et al., 1994; Ferguson et al., 1995 Ferguson et al., , 1996 Goodman et al., 1996) . At high occupancy with strong agonists, it is clear that these events cause the majority of the desensitization of the ␤AR (Clark et al., 1999) .
The current model of G protein-coupled receptor desensitization was first developed through studies of rhodopsin. Phosphorylation of the light-activated rhodopsin increased its affinity for visual arrestin (Kuhn et al., 1984) . Arrestin binding is thought to be the most critical step in desensitization, serving to uncouple rhodopsin from the G protein transducin (Wilden et al., 1986; Bennett and Sitaramayya, 1988) . Desensitization of the ␤AR is hypothesized to occur similarly, requiring receptor phosphorylation followed by ␤-arrestin binding (Lohse et al., 1990; Palczewski and Benovic, 1991) . Unlike rhodopsin, ␤AR interaction with ␤-arrestin leads to receptor internalization through a clathrincoated pit-dependent pathway Goodman et al., 1996) . Mutagenesis studies have suggested that multiple domains within visual arrestin (Gurevich and Benovic, 1993; Gurevich, 1998; Vishnivetskiy et al., 1999) and the ␤-arrestins (Kovoor et al., 1999) interact with receptor sites. The complementary domains within either rhodopsin or the ␤AR have not been identified, although they are thought to include regions that undergo agonist-induced conformational changes and phosphorylation (Kovoor et al., 1999) .
Overwhelming evidence indicates that ␤AR phosphorylation and subsequent ␤-arrestin binding are important for desensitization. Despite this, identification of the receptor sites at which GRK phosphorylation occurs and that are required for desensitization has proven difficult. In the first study of putative GRK sites, it was shown that substitution of all 11 carboxyl-terminal serines and threonines reduced GRK-mediated desensitization without affecting regulation by PKA (Bouvier et al., 1988) . Relative to the wild-type (WT) ␤AR, phosphorylation of this mutant in response to a high concentration of agonist was reduced by half but its internalization was unaffected. Sequence analysis of ␤AR phosphorylated in vitro by GRK suggested that the critical residues were in the distal portion of the carboxyl tail (Fredericks et al., 1996) . However, our recent mutagenesis studies of these sites demonstrated that they were not required for in vivo desensitization , suggesting that other regions of the receptor carboxyl tail, namely the 355-364 domain, may be important for GRK regulation. Interestingly, Hausdorff et al. (1991) found that substitution of four residues, S355, S356, T360, and S364, in the proximal portion of the ␤AR carboxyl tail (a subset of the 11 carboxyl tail serines and threonines previously described), eliminated rapid desensitization mechanisms, both PKA-and GRK-mediated. The effect on desensitization was not specific, because phosphorylation and internalization of the mutant were also completely blocked. The discrepancy between this study and the previous work in which all 11 serines and threonines were mutated led to the conclusion that the four amino acid substitutions caused an altered receptor conformation that prevented normal regulation. Adding further complexity, Yu et al. (1993) showed that substitution of serines 356 and 364 did not alter desensitization, but eliminated ␤AR internalization and resensitization. The inability of this mutant to resensitize after agonist removal led to the proposal that receptor internalization was required for the reversal of desensitization.
The inconsistencies in these reports coupled with our demonstration of the lack of effect of mutating the more distal six serines and threonines in the carboxyl tail prompted the studies presented in this article on the potential role of the S355-S364 domain in GRK-mediated desensitization. Mutants in this domain were constructed in which one (or more) of the three serine residues was substituted with alanine.
After stable transfection into human embryonic kidney (HEK) 293 cells, the mutant receptors were examined for coupling efficiency, epinephrine-induced desensitization, internalization, recycling, and phosphorylation. To focus specifically on the role of GRK-mediated desensitization, the mutants were constructed in a ␤AR in which the PKA consensus sites were ablated by substitution of serines 261, 262, 345, and 346 with alanine (designated PKA Ϫ ). Ablation of the serines of the PKA consensus sites aided analysis because previous studies have shown that PKA effects contribute to the level of overall desensitization but do not affect the component attributed to GRK-mediated homologous desensitization Clark et al. 1988; Hausdorff et al., 1989; Yuan et al., 1994) . The data reported here show that mutation of all three serines (S355,356,364) in the C-terminal domain was required for complete elimination of homologous receptor-level desensitization and for a 90 to 95% reduction in phosphorylation of the ␤AR, although mutation of only two amino acids in this cluster resulted in a dramatic reduction of desensitization. We conclude that these serines are the likely sites for GRK-meditated desensitization.
Materials and Methods
Description of Mutant ␤ARs. Mutations were introduced into the ␤AR in amino acid region 355 to 364, as shown in Table 1 and in Fig. 1 . All of the mutant ␤ARs contain alanine substitutions for the serines of the two consensus PKA sites. Mutagenesis was performed using the polymerase chain reaction as described previously . The mutants were sequenced through the entire ␤AR coding region and epitope tags to ensure accuracy of the mutagenesis procedure. All of the ␤ARs in Table 1 include the hemagglutinin (HA) epitope at the amino terminus and the 6HIS tag at the carboxyl tail, as described previously (January et al., 1997) . Recycling data also were obtained for the untagged WT␤AR, and desensitization data were obtained for both the untagged WT␤AR and for the aminoterminally HA-tagged WT␤AR. All of the plasmids were stably transfected into HEK 293 cells, as described in Table 1 .
Transfection of HEK 293 Cells. The HEK 293 cells were cultured at 37°C in 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum. The plasmids were linearized by PvuI digestion and transfected into subconfluent HEK 293 cells using the CaPO 4 method. Sixteen hours later, the cells were shocked with 25% glycerol in DMEM and placed in media containing 0.4 mg/ml G418. Stable transfectants expressing ␤AR were identified using an intact cell [ Membrane Preparation. Cells were plated into 100-mm dishes that had been precoated with poly-L-lysine. Pretreatment with epinephrine or carrier was performed in 5% CO 2 at 37°C and was stopped by removal of media followed by six 5-ml washes with ice-cold HME buffer (20 mM HEPES, pH 8.0, 2 mM MgCl 2 , 1 mM EDTA, 1 mM benzamidine, 10 g/ml trypsin inhibitor, 0.1 mg/ml BSA). The final concentration of the carrier components were 0.1 mM ascorbate and 1 mM thiourea (AT), pH 7.0. The cells were scraped (Barovsky and Brooker, 1980; Hoyer et al., 1984) . The cells were rinsed in serum-free DMEM and then removed from the plates by pipetting up and down with 0.5 ml of serum-free DMEM. Aliquots (25-50 l) of the resuspended cells were used in triplicate binding reactions, each containing about 200 pM 125 ICYP. Nonspecific binding was measured in triplicate reactions containing 1 M alprenolol. The reactions were performed on ice for 50 min and were terminated by the addition of 2.5 ml of ice-cold 50 mM Tris⅐HCl, pH 7.5, and 10 mM MgCl 2 . The 125 ICYP-bound ␤AR was collected by filtration through Whatman GF/C filters. The filters were rinsed three times with 2.5 ml of the cold Tris/MgCl 2 buffer and then counted using a Beckman 4000 gamma counter (Beckman Instruments, Columbia, MD). Protein was measured using a Bio-Rad dye reagent.
Receptor levels in cell membranes were measured in binding reactions using 5 g of membrane protein, 0.1 mM phentolamine, 40 mM HEPES, pH 7.2, 2 mM EDTA, 0.2 mM ascorbate, 2 mM thiourea, and about 200 pM 125 ICYP. Nonspecific binding was determined in the presence of 1 M alprenolol. Reactions were performed at 30°C for 50 min and terminated as described for the intact cell-binding assay.
Measurement of Equilibrium Binding Constants for ICYP and Epinephrine. The K d values for 125 ICYP and epinephrine were determined for each of the mutant ␤ARs using methods described previously (January et al., 1997 Adenylyl Cyclase Assay. Adenylyl cyclase activity was assayed using a modification of the method described by Salomon et al. (1974) . Membranes were diluted to a final protein concentration of 0.1 to 0.2 mg/ml, to achieve 5 to 10 g per reaction. Incubation was carried out at 30°C for 10 min with 40 mM HEPES, pH 7.7, 6 mM MgCl 2 , 1 mM EDTA, 100 M ATP, 1 M GTP, 0.1 mM 1-methyl-3-isobutylxanthine, 8 mM creatine phosphate, 16 U/ml creatine kinase, and 2 Ci of [␣-32 P]ATP (30 Ci/mmol; NEN Life Science Products, Boston, MA) in a total volume of 100 l. Each point was assayed in triplicate, with six to eight concentrations of epinephrine bracketing the EC 50 . The [ 32 P]cAMP produced in the assay was collected using Dowex and Alumina columns as described previously (Clark et al., 1988) . Graph-Pad software was used to estimate the EC 50 and the V max values.
Quantification of Coupling Efficiency and Desensitization. We have previously described the equation for coupling efficiency, given below 
where k 1 represents the rate constant for receptor activation by GTP for GDP exchange on the G protein, and k Ϫ1 is the first-order rate constant for inactivation. The coupling efficiency (k 1 /k Ϫ1 ) is calculated from three experimentally determined values: the K d is the low-affinity binding constant for the agonist, the EC 50 is obtained from the activation of adenylyl cyclase by agonist, and r represents B max . Eq. 1 can be combined with the equation for V max to give eq. 2, as described previously (January et al., 1997) .
The term (k 1 )r describes the receptor coupling capacity. V max is the maximum adenylyl cyclase activity measured with saturating agonist and V 100 is the theoretical value when k 1 is infinite. The extent of desensitization is quantitated as the ratio of the coupling capacity in the desensitized state relative to the naïve state. Because the values for K d and V 100 do not change with desensitization, this ratio is described by eq. 3 (January et al., 1997) .
The (k 1 r) D /(k 1 r) N term is defined as the fraction activity remaining and is calculated using experimentally determined EC 50 and V max values obtained from the dose response for epinephrine stimulation of adenylyl cyclase in the desensitized and naïve states.
Two other equations from Whaley et al. (1994) describe the changes in V max (eq. 4) and EC 50 (eq. 5) as a function of receptor level, r.
Eqs. 4 and 5 can be used to predict the changes in EC 50 and V max that occur with decreases in k 1 r as a result of desensitization or experimental manipulation of r. Whaley et al. (1994) showed that at high receptor density (Ͼ200 fmol/mg) where the EC 50 Ͻ Ͻ K d , a decrease in k 1 r resulted in a large change in EC 50 and almost no decrease in V max , a finding predicted from eqs. 4 and 5. Therefore at the high receptor densities used here, receptor-level desensitization will be represented primarily through EC 50 shifts. Thus, any significant decrease in V max for epinephrine stimulation after agonistinduced desensitization can be attributed to effects on components downstream of ␤AR/G s coupling.
Measurement of Receptor Internalization by [
3 H]CGP-12177 Binding. Epinephrine-stimulated ␤AR internalization was measured as described previously (January et al., 1997; . Cells were plated into 12-well dishes that had been precoated with poly-L-lysine to aid cell adhesion. The cells were pretreated with either carrier or epinephrine from 100ϫ stocks. Pretreatment was performed at 37°C in 5% CO 2 for various times and was stopped by removal of media followed by 6 ice-cold DMEM rinses. To each well, 1 ml of serum-free DMEM was added containing 10 nM [
3 H]CGP-12177 (CGP) to measure surface receptor number. Incubations were performed on ice for 1 h. The assays included triplicate points, and nonspecific binding was determined by inclusion of 1 M alprenolol. Some assays included 0.2% digitonin during the CGP incubation to measure total receptor number, including the internalized pool. After incubation, the CGP mixture was removed and the wells were washed twice with ice-cold PBS. The cells were scraped into 0.5 ml of trypsin and liquid scintillation counting was performed. Internalization data are plotted as the percentage of surface receptor number measured in carrier (AT)-treated samples. The data were fit to the curve for monoexponential decay and Graph Pad software was used to estimate the apparent rate of internalization.
␤AR Recycling Assay. Cells were seeded in 12-well dishes coated with poly-L-lysine and grown to confluence. The cells were pretreated with either carrier or 1 M epinephrine for 20 min. The concentration of 1 M epinephrine permitted more complete washout compared with 10 M and still provided about 70% receptor occupancy. At 20 min, the medium was removed and the cells were rinsed three times with 2 ml of warm (37°C) DMEM plus 10% fetal bovine serum and then refed with the same. The cells were incubated at 37°C for 0 to 60 min to allow recycling. Recycling was stopped by removal of media and two rinses with ice-cold PBS. Serum-free DMEM containing about 10 nM CGP was then added with and without 1 M alprenolol and the cells incubated on ice for 1 h. The CGP mixture was removed and the cells rinsed twice with ice-cold PBS. The cells were scraped into 0.5 ml of trypsin and liquid scintillation counting was performed. Surface receptor number is reported as a percentage of that found in the carrier-treated control. The return of receptors to the cell surface was fit to the curve for monoexponential decay and the rate of recycling determined. The rate of endocytosis was calculated according to eq. 6, described by Koenig and Edwardson (1994) . r surface /r total ϭ k recycling /͑k recycling ϩ k endocytosis ͒
The term r surface represents the number of receptors at the cell surface when internalization has reached steady state (after approximately 30 min of 10 M epinephrine pretreatment). The recycling rate constant, k recycling , was determined by fitting the return of receptors to the cell surface, shown in Fig. 6 , to a monoexponential decay curve.
Observation of ␤AR Internalization by Immunofluorescence. Stably transfected cells were plated on poly-D-lysine-coated #1 glass cover slips in 35-mm culture dishes, grown to 50 to 80% confluence, then chilled on ice. Monoclonal antibody mHA.11 (Berkeley Antibody Co., Berkeley, CA) was added to 2 g/ml and the incubation on ice continued for 60 min. The monolayers were washed three times with ice-cold medium, then warmed to 37°C for 5 min or 30 min in the presence or absence of 10 M isoproterenol. The monolayers were then rapidly chilled, washed once with PBS containing 1.2% sucrose (PBSS) and fixed at 4°C for 10 min with PBSS containing 4% paraformaldehyde (Electron Microscopy Sciences, Ft. Washington, PA). The fixed cells were incubated in 0.34% L-lysine, 0.05% Na-m-periodate in PBSS for 20 min, washed, and permeabilized with 0.2% Triton X-100 for 5 min, then blocked for 15 min with 10% heat-inactivated goat serum. Goat anti-mouse IgG conjugated with Alexa Fluor 488 (Molecular Probes, Eugene, OR), diluted to 5 g/ml in PBSS with 0.2% heat-inactivated goat serum and 0.05% Triton X-100, was added to the cells and left overnight in the dark. The cover slips were mounted in Mowiol (Calbiochem, La Jolla, CA) and imaged with a DeltaVision Restoration Microscopy System (Applied Precision, Issaquah, WA). The digitized images were then deconvoluted with a DeltaVision workstation running DVSoftWoRx and assembled using Adobe Photoshop 5.5 (Adobe Systems, Mountain View, CA).
Determination of ␤AR Phosphorylation. The methods used are modifications of those described previously (January et al., 1997) . Cells were plated into 100-mm dishes precoated with poly-L-lysine and grown to confluence. Cells were rinsed once with phosphate-free DMEM and then incubated with 0.5-mCi [
32 P]orthophosphate in phosphate-free DMEM containing 1% fetal bovine serum for 3 h at 37°C in 5% CO 2 . The labeling medium was removed and replaced with 5 ml of bicarbonate-and phosphate-free DMEM containing 10% FBS. After 30 min equilibration the cells were treated with 10 M epinephrine or AT carrier for the indicated times. The medium was removed and the cells rinsed with 5 ml ice-cold PBS. The dishes were placed on ice and scraped into 3 ml of PBS containing 10 g/ml leupeptin and 100 nM okadaic acid. The cells were collected by centrifugation at 2000 rpm in an IEC DPR 6000 centrifuge. The cell pellet was solubilized by vortexing in buffer containing 20 mM HEPES, pH 7.4, 300 mM NaCl, 0.8% n-dodecyl-␤-D-maltoside (DBM), 5 mM EDTA, 3 mM EGTA, 20 mM sodium pyrophosphate, 10 mM sodium fluoride, 25 mM imidazole, 10 g/ml benzamidine, 10 g/ml trypsin inhibitor, 100 nM okadaic acid, 10 g/ml leupeptin, and 14 mM ␤-mercaptoethanol. After 30 min rocking at 4°C, the solubilized cells were centrifuged for 30 min at 45,000 rpm in a Beckman 50 Ti rotor.
After solubilization, the ␤AR was purified using either of two procedures. Procedure 1 used for the majority of experiments consisted of a Ni-NTA affinity step followed by either wheat germ agglutinin-agarose (WGA) chromatography or immunoprecipitation. The solubilized supernatant was applied to Ni-NTA superflow resin (Qiagen, Valencia, CA) packed into disposable columns (Bio-Rad), 0.8 ml of 2ϫ slurry per column. The eluate was collected and recycled onto the columns. The columns were washed once with 5 ml of buffer containing 0.05% DBM, 20 mM HEPES, pH 7.4, 300 mM NaCl, 25 mM imidazole, 4 M guanidine HCl, and 1 M LiCl. After a rinse with 5 ml of Ni 2ϩ column buffer (0.05% DBM, 20 mM HEPES, pH 7.4, 300 mM NaCl, 25 mM imidazole), the ␤AR was eluted in a single step with 4 ml of buffer containing 0.05% DBM, 20 mM HEPES, pH 7.4, 300 mM NaCl, and 100 mM imidazole. The ␤AR was further purified using either WGA or immunoprecipitation. Similar results were obtained with both procedures. The WGA step was performed as described previously (January et al., 1997; Seibold et al., 1998) . For immunoprecipitation, each 4-ml Ni 2ϩ column eluate was precleared with 50 l of a 2ϫ protein A Sepharose slurry (Pharmacia, Piscataway, NJ). Preclearing was performed in a 1 h incubation at 4°C with rocking. Samples were centrifuged at 2000 rpm in the IEC DPR 6000, the supernatants were transferred to fresh tubes, and 20 l (4 g) of anti-␤AR antibody added (antibody SC-569 directed against the C-terminal 20 amino acids; Santa Cruz Biotechnology, Santa Cruz, CA). The samples were incubated for 90 min at 4°C with rocking, after which 50 l of Protein A Sepharose was added and the samples further incubated for 1 h at 4°C with rocking. The immune complexes were centrifuged for 5 min in the IEC DPR 6000, the supernatants aspirated, and the pellets washed twice with 2 ml of Ni column buffer. To each pellet was added 125 l of SDS sample buffer (50 mM Tris, pH 6.8, 2% SDS, 0.025% bromphenol blue, 6 M urea, and 14 mM ␤-mercaptoethanol). The samples were incubated at 60°C for 15 min with frequent vortexing. The samples were transferred to Eppendorf tubes, briefly spun in a Microfuge and loaded onto 7.5% SDS-polyacrylamide gels along with prestained molecular mass markers. After electrophoresis, the proteins were transferred from the gel to 0.22-m polyvinylidene difluoride (PVDF) membranes.
In the course of these studies, a substantially modified procedure was developed that allowed better recovery and considerably improved quantification and will be referred to as procedure 2. In outline, this procedure consisted of a C-tail antibody affinity column, N-glycosidase F treatment of the antibody column eluate, and a Talon affinity resin step (Co 2ϩ -carboxymethylaspartate-agarose; Clontech, Palo Alto, CA). Solubilized ␤AR (equal amounts from control and epinephrine-treated based on ␤AR levels in the extracts) was applied to a 100-l packed volume of antibody resin in a column (SC-569 C-tail antibody from Santa Cruz linked to agarose) that had been prewashed with PBS, pH 7.0. After recycling the extract three times through the column, it was washed once with 3 ml of 10 mM phosphate buffer, pH 6.8, containing 0.05% DBM. The ␤AR was eluted with 1 ml of 100 mM glycine buffer, pH 2.5, plus 0.05% DBM and the eluate collected in 0.3 ml 1 M phosphate buffer, pH 8.0 for neutralization. The eluate was digested with 1500 units of N-glycosidase F (New England Biolabs, Beverly, MA) for 2 h at 37°C, and applied to the Talon Co 2ϩ -carboxymethylaspartate-agarose column (0.5 ml packed resin) that had been prewashed with Talon buffer (0.05% DBM, 20 mM HEPES, pH 7.4, 150 mM NaCl) and recycled through the resin two times. The column was washed twice with Talon buffer, once with 4 ml of 10 mM imidazole, and finally with 0.25 ml of 20 mM imidazole, all in the same buffer. The ␤AR was eluted with 0.75 ml of Talon buffer containing 100 mM imidazole and concentrated to 50 l in a centricon (Amicon; 30-kDa cutoff). SDSsample buffer was added to the 50 l of eluate and heated at 60°C for 15 min. Samples were run on SDS-polyacrylamide gel electrophoresis (PAGE; 12% gel) and transferred to nitrocellulose.
PhosphorImager analysis was performed on the PVDF or nitrocellulose membranes from either procedure using a Molecular Dynamics Storm PhosphorImager model 860 and ImageQuant software (Molecular Dynamics, Sunnyvale, CA). Western blotting was performed using the anti-HA antibody or the anti-carboxyl terminal ␤AR antibody as the primary antibody as described previously . After incubation with the secondary antibody, a horseradish peroxidase-conjugated goat anti-rabbit (Bio-Rad) antibody, enhanced chemiluminescence was performed.
Results
Determination of the Coupling Efficiency for Epinephrine Activation of Adenylyl Cyclase for the HA-␤AR-6HIS and Mutant ␤ARs. To eliminate the possibility that the mutations we introduced into the ␤AR caused nonspecific effects on coupling, we determined the coupling efficiency value for each mutant using eq. 1. Calculation of coupling efficiency requires measurement of receptor number, the low-affinity K d value for agonist binding, and the EC 50 value for adenylyl cyclase activation . We calculated the coupling efficiency for at least two clones of each mutant. The coupling efficiencies and the experimentally determined values used in its calculation are summarized in Table 2 . None of the mutant receptors showed a significant alteration of the K d value for epinephrine binding relative to the HA-␤AR-6HIS or the PKA Ϫ . The variation we observed in coupling efficiencies in this study are typical and reflect the variation in the three parameters used in the calculation of coupling efficiency.
Desensitization of the HA-␤AR-6HIS and Mutant ␤ARs. To measure desensitization, cells expressing the mutant ␤ARs were pretreated with 10 M epinephrine or carrier for various times. Membranes were prepared and assayed for activation of adenylyl cyclase with a range of epinephrine concentrations. Figure 2 shows typical data from epinephrine dose-response curves in which adenylyl cyclase activity was measured in membranes prepared from cells pretreated with carrier (control) or 10 M epinephrine for 2 or 5 min. The increase in EC 50 value and the decrease in the V max value with 10 M epinephrine pretreatment were measured in many experiments, such as those in Fig. 2 , and used to calculate desensitization as fraction activity remaining for the various pretreatment times (1 to 30 min), as summarized in Fig. 3 . Compared with the HA-␤AR-6HIS and the PKA Ϫ , the triple and double mutants showed greatly reduced desensitization. Desensitization was measured in at least two clones for each mutant. For the 30-min pretreatment with 10 M epinephrine, the percentage of activities remaining for the HA-␤AR-6HIS, PKA Ϫ , S355,356,364A, S355,356A, and S356,364A, respectively, were 3% Ϯ 0.3, 8% Ϯ 1.0, 72% Ϯ 8, 28% Ϯ 4, and 64% Ϯ 15. Relative to PKA Ϫ , these values are 9 (S355,356,364A), 3 (S355,356A), and 8 (S356,364A) times greater and highly significant (P Ͻ .001). Compared with HA-␤AR-6HIS, these values are 24, 9, and 21 times greater for the triple-and double-serine mutants. The PKA Ϫ mutant provides the most appropriate comparison because all of the mutant ␤ARs described here contain alanine substitutions for the serines of consensus PKA sites. The two single-serine substitutions, S356A and S364A, were not as effective as the double mutants in impairing desensitization. However, the percentage of activities remaining after 30-min desensitization were 16% Ϯ 3 and 20% Ϯ 1, which differed significantly from the PKA Ϫ (P Ͻ .05). Although the various serine substitutions caused reductions in the right shift of the EC 50 for epinephrine stimulation of adenylyl cyclase after epinephrine-induced desensitization, the mutations had no significant effect on the epinephrine-induced decrease in the V max (Figs. 2 and 3) . To show more clearly the differential effect of the mutants on these two parameters, the fold increase in EC 50 and the percentage decrease in V max after 5 min of epinephrine pre- Fig. 4 and Table 3 . The triple serine mutation completely eliminated the epinephrine-induced increase in the EC 50 , whereas the EC 50 of the PKA Ϫ and HA-␤AR-6HIS increased 3.4-fold and 10.8-fold, respectively. For the S355,356A and S356,364A mutants the EC 50 after desensitization increased 1.5 and 1.2-fold, respectively. In contrast to the EC 50 changes, the extent of the epinephrineinduced decrease in V max was similar for the mutant ␤ARs, PKA Ϫ , and HA-␤AR-6HIS (Table 3) , ranging between 31.0 and 47.7%. The data show that the reduced desensitization measured for the 355-364 domain mutants resulted from inhibition of EC 50 shifts rather than V max effects.
This lack of effect of the mutants on the V max is consistent with the predictions from eqs. 4 and 5 under Materials and Methods and the data in Whaley et al. (1994) , that changes in the EC 50 value rather than changes in V max values are the primary effects of receptor level desensitization at the high receptor densities used in these experiments. The data strongly suggest that the V max changes we observe are downstream of receptor/G s coupling. To explore this possibility, we examined the effects of 10 M epinephrine-induced desensitization (5-min pretreatment) on prostaglandin E 1 (PGE 1 ), GTP␥S, and forskolin stimulation. We found this treatment of the PKA Ϫ cells caused decreases in both PGE 1 (10 M) and GTP␥S (10 M) stimulation of adenylyl cyclase (54 Ϯ 5.4% and 25.4 Ϯ 6.7% respectively). The effects on PGE 1 and GTP␥S stimulation support our suggestion that there is probably downstream desensitization. Similar effects of epinephrine-induced desensitization on these two activities were observed in the HA-␤AR-6HIS. Forskolin (20 M) stimulation was reduced only 8 to 14% in these cell lines, which is perhaps not surprising given that forskolin activates all adenylyl cyclases except type 9 and is unlikely to activate only that adenylyl cyclase coupled to the ␤AR. In fact, maximal forskolin activation is about double that of the maximal epinephrine stimulation.
Another possibility we evaluated was whether stimulation of G i contributed to the epinephrine-induced decrease in V max . To test this, HA-␤AR-6HIS and the PKA Ϫ cells were treated overnight in the presence or absence of pertussis toxin (100 ng/ml) and then desensitized by a 5-min treatment with epinephrine. Although pertussis toxin predictably increased the V max value for epinephrine stimulation of adenylyl cyclase in both controls and epinephrine-treated cells, it did not alter either the extent of the desensitization-induced decrease in the V max values for epinephrine stimulation of adenylyl cyclase or the overall extent of the desensitization.
Internalization and Recycling of the Mutant ␤ARs. Cells expressing the various ␤ARs were exposed to 10 M epinephrine for various times, and receptor internalization Fig. 5 as the loss of surface receptor with time of epinephrine treatment. After 30 min of 10 M epinephrine pretreatment, the percentage of surface receptors internalized was 79% (Ϯ2, n ϭ 8), 66% (Ϯ2, n ϭ 4), and 72% (Ϯ2, n ϭ 4), for the HA-␤AR-6HIS, PKA Ϫ , and S356A, respectively. The extent of internalization measured for the double mutants S355,356A and S356,364A and for the S364A mutant was reduced, with values of 52% (Ϯ3, n ϭ 6), 53% (Ϯ3, n ϭ 5), and 51% (Ϯ4, n ϭ 5), respectively, a decrease of about 20% compared with PKA Ϫ . The triple-serine mutation caused the greatest decrease in the extent of internalization, giving a value of 36% (Ϯ3, n ϭ 3). Fit of the averaged data shown in Fig. 5 to the curve for monoexponential decay showed that the observed rate of internalization was also reduced for the double, triple, and S364A mutants. The k obs determined for the HA-␤AR-6HIS, PKA Ϫ , and S356A was 0.19 min Ϫ1 , whereas that determined for the triple and double mutants and S364A was 0.11 min Ϫ1 , a reduction of 42%. The correlation coefficients for the first-order decay curves were 0.996 or better for the different mutants.
[
3 H]CGP-12177 binding performed in the presence of digitonin showed no loss of total ␤AR number during the internalization time course.
The rate of internalization is a composite of the rates of endocytosis and recycling (Morrison et al., 1996; Clark et al., 1999) . Therefore, the rate of endocytosis can be calculated from the rate of recycling and the ratio of surface receptors to the total receptor number at steady state (eq. 6 under Materials and Methods). Determination of the recycling rate was necessary before concluding that the reduced observed rate of internalization for the double mutants and for S364A resulted from a reduced rate of endocytosis. To measure the rate of recycling, cells expressing the HA-␤AR-6HIS, the PKA Ϫ , or the double and triple mutant ␤ARs were pretreated with 1 M epinephrine for 20 min, then rinsed to remove the hormone, and incubated for various times to allow the recycling of the ␤ARs to the cell surface. The return of the ␤ARs to the cell surface was measured by [ 3 H]CGP-12177 binding (Fig. 6) . The HA-␤AR-6HIS and mutant ␤ARs all recycled to the cell surface after washout of epinephrine with similar rate constants, estimated from fit of the data to a monoexponential decay curve. From the average value of the rate constants, a recycling t 1/2 of 10 min (k recycle ϭ 0.07) was determined. Because the HA-␤AR-6HIS and mutant ␤ARs were found to recycle at the same rate, the differences in the rate and extent of internalization indicate different rates of Fig. 3 . Time course of HA-␤AR-6HIS and mutant ␤AR desensitization in response to 10 M epinephrine. Cells expressing the HA-␤AR-6HIS (Ⅺ), the PKA Ϫ (E), S355,356A (OE), S356,364A (), S356A (ࡗ), S364A (f), or S355,356,364A (ƒ) were pretreated with carrier or 10 M epinephrine for various times from 1 to 30 min. Membranes were prepared and assayed for epinephrine-stimulated adenylyl cyclase activity as described under Materials and Methods. The values for fraction activity remaining were calculated according to eq. 3. Each point was calculated using data from at least three experiments, except for the 10 min data for S355,356,364A and the 30 min data for the single mutants, S356A and S364A, where n ϭ 2. Each experiment included separate adenylyl cyclase dose response curves for the epinephrine treated and carrier (control) pretreated samples. Each point in the adenylyl cyclase dose response curves was the average of triplicates. Fig. 4 . EC 50 changes in response to epinephrine pretreatment in the HA-␤AR-6HIS and mutant ␤ARs. The data summarized in Fig. 3 were analyzed for the increase in EC 50 value that occurred in response to the 5-min pretreatment with 10 M epinephrine. The fold increase in EC 50 value measured with epinephrine treatment was calculated relative to the EC 50 value of the carrier-treated control. A 1-fold increase indicates no change. The data are given as the mean Ϯ S.E.M. For the S356A mutant, n ϭ 3. For all the other ␤ARs, n Ն 6. * indicates significantly different from PKA Ϫ , as determined by an unpaired t test at P Ͻ .0004. The ** indicates significantly different from PKA Ϫ , as determined by an unpaired t test at P Ͻ .0001. The data summarized in Fig. 3 was analyzed for the decrease in V max that occurred in response to the 5-min pretreatment with 10 M epinephrine. The percentage decline in V max measured with epinephrine pretreatment was calculated relative to the V max of the carrier-treated control. The values are the mean Ϯ S.E.M.
Cell Line
V max % Decrease HA-␤AR-6HIS 41.2% Ϯ 10, n ϭ 17 PKA Ϫ 42.0% Ϯ 15, n ϭ 10 S356A 47.7% Ϯ 13, n ϭ 3 S364A 37.9% Ϯ 11, n ϭ 9 S355,356A
35.0% Ϯ 26, n ϭ 9 S356,364A
35.0% Ϯ 24, n ϭ 6 S355,356,364A
31.0% Ϯ 3, n ϭ 7 ). Using this value, it can be calculated that the rate of endocytosis of the triple mutant is reduced about 70% relative to PKA Ϫ . It was recently reported that the addition of various amino acids to the ␤AR carboxyl terminus inhibited receptor recycling to the plasma membrane (Cao et al., 1999) . We measured internalization and recycling of the untagged WT␤AR and found the data to be similar to those obtained for the HA-␤AR-6HIS. In response to a 20-min pretreatment with 1 M epinephrine, 66.2% (Ϯ2.77, n ϭ 5) of the HA-␤AR-6HIS, and 68.5% (Ϯ1.85, n ϭ 2) of the untagged WT␤AR were internalized. After removal of epinephrine and a 60 min recycling incubation, all but 16.7% (Ϯ3.09, n ϭ 5) of the HA-␤AR-6HIS, and 19.9% (Ϯ1.70, n ϭ 2) of the untagged WT␤AR had returned to the plasma membrane.
Observation of ␤AR Internalization Using Deconvolution Microscopy. Cells expressing the PKA-or the triple and double mutants were incubated with antibody directed against the amino-terminal HA epitope tag, followed by treatment with either carrier or 10 M isoproterenol for 5 or 30 min. The cellular location of the receptors in response to isoproterenol treatment was determined using immunofluorescent deconvolution microscopy. In the absence of agonist, all of the antibody-labeled mutant receptors remained at the cell surface. In the presence of agonist, there was rapid and substantial receptor internalization of the double mutants into peripheral endocytic vesicles (Fig. 7) . The triple mutant seemed to internalize somewhat more slowly. Similar results were obtained using 10 M epinephrine (data not shown). Although the immunofluorescent studies are not easily quantified, they are consistent with the results of CGP binding Phosphorylation of the Mutant ␤ARs in Response to 10 M Epinephrine. Cells expressing the PKA Ϫ , S355,356A or the S356,364A mutant ␤ARs, were labeled with [ 32 P]orthophosphate and then treated with either 10 M epinephrine or carrier for 2 min. The cells were solubilized and the ␤AR protein purified by procedure 1 as described under Materials and Methods. The purified ␤AR was subjected to SDS-PAGE and transferred to a PVDF membrane. The PhosphorImager analysis of a representative experiment is shown in Fig. 8A . To estimate relative loading, a Western blot was performed on the same membrane, using antibody directed against the ␤AR carboxyl terminus (Fig. 8B) . The data are representative of 4 independent experiments and show that the double mutants are rapidly phosphorylated in response to epinephrine pretreatment. Phosphorylation of the PKA Ϫ increased 7-fold in response to a 2-min pretreatment with 10 M epinephrine, whereas phosphorylation of the double mutants S355,356A and S356,364A increased only 3.3-to 4-fold (Fig. 9) . The time courses of phosphorylation of the double mutants and PKA Ϫ were similar (data not shown), showing a maximum level at 2 to 5 min, after which phosphorylation declined.
To measure the phosphorylation of the double and triple serine mutant relative to the PKA Ϫ , [ 32 P]labeled cells were pretreated with epinephrine for 2 min and the ␤ARs purified by procedure 2 as discussed under Materials and Methods. The PhosphorImager scan and accompanying Western blots of a typical experiment (including comparison with S356,364A) are shown in Fig. 10 . In this purification procedure, the glycosyl residues are removed by treatment with N-glycosidase F (between the antibody affinity and the Talon affinity steps); this results in the migration of the ␤AR to a molecular mass of Х 48 to 50 kDa. The Western blot using the anti-HA antibody shows that similar levels of ␤AR were purified from the three cells lines (each antibody column was loaded with 375 fmol of solubilized ␤AR). The 2-min epinephrine treatment of the triple serine mutant and PKA Ϫ caused 2-and 15-fold increases in phosphorylation over basal, respectively. Phosphorylation of the double mutant was 6.4-fold over basal (i.e., 39% of PKA Ϫ ). From three independent experiments, including the one in Fig. 10 , we found the fold stimulation of the triple mutant over basal was 1.86 Ϯ 0.18-fold compared with 16.6 Ϯ 3.8 for PKA Ϫ . Thus the epinephrine-stimulated phosphorylation of the triple mutant is only ϳ5% that of the PKA Ϫ . Nevertheless it is important to emphasize that phosphorylation was not eliminated.
It can be seen that procedure 2 focuses the ␤AR to a tight band, greatly improving our ability to quantify 32 P relative to the glycosylated ␤AR that spreads over a 15-to 20-kDa region of the gels. Additionally we have found that the background is reduced resulting in larger fold-stimulations relative to procedure 1.
Discussion
Our data show that mutations of either two or three of the serines in the ␤AR 355-364 domain caused a striking reduction in epinephrine-induced receptor-level desensitization of the ␤AR (EC 50 -shift) without altering the decrease in V max that seems to be downstream. These mutations were made in a receptor in which both PKA consensus sites were ablated to eliminate any contribution of PKA desensitization of the ␤AR. The complete elimination of the EC 50 shift in the Fig. 8 . Phosphorylation of the PKA Ϫ and double mutant ␤ARs in response to a 2 min pretreatment with 10 M epinephrine. Cells expressing the PKA Ϫ , the S355,356A or the S356,364A mutant, were labeled with 32 P orthophosphate for 3 h and then exposed to either 10 M epinephrine (epi) or carrier (c) for 2 min. The cells were solubilized and the receptor protein purified using Ni column chromatography and immunoprecipitation, as described by procedure 1 in "Materials and Methods". The receptor protein was resolved by SDS-PAGE and transferred to a PVDF membrane. A, PhosphorImage of the PVDF membrane. Western blot analysis (B) was performed on the same membrane using antibody directed against the ␤AR carboxyl terminus. The data are representative of four similar experiments. Fig. 9 . Phosphorylation of the PKA Ϫ and double mutant ␤ARs measured as fold increase. Cells expressing the PKA Ϫ , S355,356A, or S356,364A mutant ␤ARs were pretreated with 10 M epinephrine or carrier for 2 min. The cells were solubilized and the ␤AR purified as described by procedure 1 under Materials and Methods. The fold increase in phosphorylation was determined by dividing the cpm obtained after epinephrine treatment with that measured in the basal, carrier-treated state. The data represent the mean Ϯ S.E.M. of at least four experiments for each receptor type. * indicates significantly different from PKA Ϫ by an unpaired t test at P Ͻ .05. S355,356,364A mutant coupled with the 90 to 95% loss of phosphorylation and considerably reduced extent of internalization (45%) relative to PKA Ϫ are consistent with the proposal that the crucial sites for homologous GRK-mediated desensitization of the ␤AR lie in the 355 to 364 amino acid region with the caveat that phosphorylation was not eliminated. Our data are consistent as well with the studies of rhodopsin phosphorylation by GRK1 (rhodopsin kinase). Two serines in the carboxyl tail of mouse rhodopsin are phosphorylated in vivo in response to light (Ohguro et al., 1995) . These two serines lie in the region of rhodopsin most homologous to the 355 to 364 domain of the ␤AR [see Collins et al. (1991) for amino acid alignment]. In addition, in vitro studies have shown that rhodopsin kinase can phosphorylate the ␤AR (Benovic et al., 1986) , and GRK2 (␤ARK1) can phosphorylate rhodopsin (Benovic et al., 1987) . The evidence suggests that the ␤AR and rhodopsin share similar sites for recognition by their respective kinases. Table 3 and Fig. 4 show further that the decreased desensitization of the triple and double mutants is almost completely attributable to the lack of change of the EC 50 for epinephrine stimulation. What little desensitization is observed with S355,356,364A and S356,364A is caused for the most part by the decrease in the V max value. This is not significantly different from the decrease in V max values observed with the PKA Ϫ or the HA-␤AR-6HIS (Table 3) , demonstrating that the disruption of desensitization found in serine substitution mutants of the ␤AR 355-364 region results from changes in values of EC 50 rather than those of V max . Loss of ␤AR/G s coupling with receptor-level desensitization is predicted (by eqs. 4 and 5 under Materials and Methods) to be represented primarily by changes in the value of EC 50 rather than changes in that of V max at the high receptor density reported here . The epinephrine-induced decreases in PGE 1 and GTP␥S stimulation of adenylyl cyclase support the idea that there is significant heterologous downstream desensitization. Unfortunately, we were unable to detect significant decreases in forskolin stimulation with desensitization; however, as noted previously, this could be explained by the fact that forskolin activates all adenylyl cyclases except type 9, and this may obscure the contribution of the subtype altered by the epinephrine pretreatment. The contribution of G i to the 40% decrease in V max was also explored through the use of pertussis toxin and found not to contribute either to the V max or to the overall desensitization. At present therefore, the cause of the decrease in V max in these cells remains unexplained; however, the cells expressing the triple mutant will be ideal for examining this phenomenon in future studies because the V max effect is not complicated by receptor-level changes.
Although receptor-level desensitization of the double mutants was greatly impaired relative to the HA-␤AR-6HIS and PKA Ϫ , internalization and phosphorylation were not comparably reduced. We considered how our results could be reconciled with the currently accepted scheme for the ␤AR desensitization process which proposes that GRKphosphorylation of the ␤AR is followed by ␤-arrestin binding, ␤-arrestin-promoted endocytosis, and subsequent recycling (Krupnick and Benovic, 1998; Lefkowitz et al., 1998; Clark et al., 1999) . Each step in this scheme of ␤AR regulation, including GRK phosphorylation, ␤-arrestin binding, and internalization, is dependent on the previous step. However, as we have shown previously in HEK 293 cells, the inter-relationships between these processes during the time of agonist stimulation are complex (January et al., 1997) . Phosphorylation of the ␤AR shows a rapid rise, reaches a maximum by 2 to 5 min, and then declines, whereas levels of endocytosed ␤AR continue to increase until a steady state of endocytosis and recycling is achieved.
The most straightforward conclusion is that our double mutants have ablated two of the three crucial GRK sites that are required for ␤-arrestin-mediated desensitization, but that the additional GRK site must be blocked to achieve near complete blockade of ␤-arrestin binding. The first evidence for multisite interaction between receptors and arrestin came from studies of rhodopsin and visual arrestin. Mutagenesis studies showed that at least three regions of visual arrestin interact with phosphorylated, light-activated rhodopsin to terminate signaling (Gurevich and Benovic, 1993; Gurevich, 1998; Vishnivetskiy et al., 1999) . Similar work suggests that multisite binding mediates ␤-arrestin-␤AR interaction (Kovoor et al., 1999) . Although domains of arrestin and ␤-arrestin important for receptor interaction have been identified, the corresponding sites in the respective receptors were not known previously. Regions of the receptors likely to be important for arrestin interaction include GRK-phosphorylated residues, the third intracellular loop (a region important for contact with G proteins), and undefined domains that result from agonist binding-induced conformational change (Gurevich and Benovic, 1993; Krupnick et al., 1994; Gurevich, 1998; Kovoor et al., 1999; Vishnivetskiy et al., 1999) . In support of this model, the recently determined crystal structure of visual arrestin provided a firm structural basis for the proposed conformational alterations of arrestin and multisite binding to receptor (Granzin et al., 1998; Hirsch et al., 1999) .
Given the validity of the multisite model of ␤-arrestin binding to the ␤AR, there are several schemes consistent 32 P]orthophosphate for 3 h and then exposed to either 10 M epinephrine (epi) or carrier (c) for 2 min. The cells were solubilized and the receptor protein purified using antibody and Talon chromatography and digested with PNGase F, as described by procedure 2 under Materials and Methods. The receptor protein was resolved by SDS-PAGE and transferred to a nitrocellulose membrane. A, PhosphorImage of the nitrocellulose membrane. B, Western blot analysis was performed on the same membrane using antibody directed against the HA epitope in the ␤AR amino terminus. The data are representative of three experiments performed with the PKA Ϫ and the S355,356,364A mutant, and two experiments performed with the S356,364A mutant.
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at ASPET Journals on August 15, 2017 molpharm.aspetjournals.org with our desensitization, phosphorylation, and internalization data. When agonist-bound, the double or triple mutants may retain sites for low-affinity ␤-arrestin interaction sufficient to promote internalization, albeit at a reduced rate, but not adequate to provide a stable, uncoupled state of the ␤AR at the cell surface. A mutagenesis study of the m 2 muscarinic receptor provides precedent for this scheme. Although two regions of the third intracellular loop were phosphorylated in response to agonist, mutagenesis of either region alone did not reduce receptor phosphorylation or internalization, and were described as "redundant" for these functions (Pals-Rylaarsdam and Hosey, 1997). In contrast, desensitization was eliminated by mutagenesis of the more carboxyl terminal region. The m 2 muscarinic receptor study and our results support the model of multisite receptor-␤-arrestin interaction and demonstrate that selective mutagenesis of the receptor can identify a subset of GRK phosphorylation sites important for high-affinity ␤-arrestin binding and desensitization but possibly leave intact other weak ␤-arrestin interaction sites that contribute to endocytosis.
As an alternative to the model of multisite ␤AR-␤-arrestin interaction, the data reported here may indicate the existence of a separate but minor internalization pathway that is not dependent on receptor phosphorylation by GRK or ␤-arrestin binding. Arrestin-independent internalization pathways have been reported for the m 1 , m 3 , and m 4 muscarinic receptors (Lee et al., 1998) and the angiotensin II type 1A receptor (Zhang et al., 1996) . An internalization pathway that is independent of ␤-arrestin and GRK phosphorylation, but dependent on PKA, was reported for the secretin receptor (Walker et al., 1999) . In addition, dominant negative ␤-arrestin does not completely block ␤AR internalization , perhaps because of the contribution of a ␤-arrestin-independent pathway. These studies suggest that the lack of correlation between the extent of ␤AR desensitization and internalization reported here may result from the use of an alternate internalization pathway that depends on agonist binding but not GRK phosphorylation or ␤-arrestin binding. Based on this model, the absence of crucial GRK phosphorylation sites in the serine mutants of the 355 to 364 domain would not block internalization through the alternate pathway.
Still another possibility that must be considered is based on our observation of a 2-fold phosphorylation in the triple mutant, even while receptor-level desensitization was eliminated. This result leaves open the possibility that there is an as-yet-unidentified phosphorylation site that could be involved in endocytosis of the ␤AR because the inhibitory effect of the triple mutant on endocytosis was far from complete. Further studies will be required to evaluate the location of this site and its possible contribution to internalization.
Regardless of which model best explains our results, the data described here resolve previous conflicting reports on the function of the ␤AR carboxyl tail serines and threonines (Bouvier et al., 1988; Hausdorff et al., 1989; Hausdorff et al., 1991; Yu et al., 1993) . Although Hausdorff et al. reported global, nonspecific effects by substitution of four amino acids in the 355-to-364 region, we show that substitution of only two residues in this domain significantly reduces agonistinduced desensitization while only partially inhibiting internalization and phosphorylation. The selective mutagenesis strategy employed here more specifically impaired desensitization. The report that glycine substitution of serines 356 and 364 blocked internalization and resensitization without affecting desensitization (Yu et al., 1993) is very difficult to reconcile with our results. We found that alanine substitution of these same sites (S356,364A) resulted in only a partial inhibition of internalization, and recycling was unaffected. It is possible to rationalize the conflicting results if glycine and alanine substitution cause significantly different effects. In addition, their work was carried out in Chinese hamster ovary (CHO) cells, rather than the HEK 293 cells used here, and ␤AR internalization is greatly reduced in CHO cells compared with HEK 293 (Menard et al., 1997) . Therefore a small effect of the mutations on the extent of internalization in HEK 293 cells may be a major effect in CHO cells.
We found that mutations of the ␤AR 355-364 domain did not affect recycling, because all of the mutants recycled with kinetics indistinguishable from those of HA-␤AR-6HIS. However, we considered whether the carboxyl terminal HIS 6 tag, included in the HA-␤AR-6HIS and all the mutant ␤ARs described here, might inhibit receptor recycling relative to the untagged WT␤AR. It was recently reported that the addition of various amino acids to the ␤AR carboxyl terminus inhibited recycling to the cell surface (Cao et al., 1999) . The study proposed that additions to the carboxyl terminus block the receptor PDZbinding domain, composed of the last three amino acids, from mediating the protein-protein interactions required for recycling. We tested the effect of the HIS 6 tag by comparing recycling of the HA-␤AR-6HIS and the untagged WT␤AR. As we report here, the recycling of the HA-␤AR-6HIS and the untagged WT␤AR were indistinguishable. Our data are similar to those of Kallal et al. (1998) , who found similar internalization and recycling for both the untagged WT␤AR and the ␤AR labeled at the carboxyl terminus with green fluorescent protein.
The kinetic data we obtained were similar to those of Morrison et al. (1996) , who described the internalization and recycling of the HA-␤AR, which has an untagged carboxyl tail. In addition, we found that the HIS 6 tag did not affect ␤AR desensitization. Comparison of the HA-␤AR-6HIS with the untagged WT␤AR showed that their desensitization was similar, in agreement with previous work (January et al., 1997) . After 30-min pretreatment with 10 M epinephrine, the fraction activity remaining for the HA-␤AR-6HIS, HA-␤AR, and untagged WT␤AR was 0.03 (Ϯ0.003, n ϭ 9), 0.06 (Ϯ0.01, n ϭ 6), and 0.07 (Ϯ0.01, n ϭ 6), respectively. We show that agonist-induced desensitization, internalization, and recycling are clearly not impaired by addition of the HIS 6 epitope tag to the receptor carboxyl terminus. However, we must be open to the possibility that there may be important cell-specific differences in the effects of C-terminal epitope tags that clearly block interactions with PDZ domain-containing proteins such as HNERF (Hall et al., 1998) .
Previous work showed that both PKA-and GRK-dependent mechanisms contributed to receptor level desensitization of the ␤AR (Hausdorff et al., 1989; Yuan et al., 1994) . The functional importance of the PKA consensus sites found in the third intracellular loop and carboxyl terminus of the ␤AR has been supported by mutagenesis studies (Hausdorff et al., 1989; Yuan et al., 1994) and by the use of S49 lymphoma cells lacking either G s or PKA activity Clark et al., 1988) . Identification of the sites required for GRK-dependent, homologous desensitization has been more difficult. This is understandable in ret- rospect given that it seems that GRK-mediated phosphorylation, ␤-arrestin binding, internalization, and recycling may be tightly linked (Krupnick and Benovic, 1998; Lefkowitz et al., 1998; Clark et al., 1999) and, in addition, further confounded by PKA-mediated desensitization when concentrations of epinephrine in the pretreatment are high. In this article, isolation of GRK-mediated receptor desensitization and thereby simplification of its analysis was achieved by substitution of the serines in the two PKA consensus sites. Our work provides strong evidence that the serines in the ␤AR 355 to 364 play a key role in GRK-dependent desensitization.
